CD276 and osteosarcoma: The B7-H3 targeted CAR-T cells we constructed showed the strong B7-H3-specific tumor cell killing ability in vitro and significant tumor-suppression effect in the PDX model in vivo, which demonstrated its enormous potency to be used for treating osteosarcoma in the clinical trials in the future.